Healthcare's federal COVID-19 aid totals $412B

A significant portion of COVID-19 aid authorized at the federal level has been earmarked for the healthcare industry — to the tune of $412 billion, according to the Committee for a Responsible Federal Budget.

The committee's COVID Money Tracker tool follows aid authorizations from Congress, the Federal Reserve and the Trump administration during the COVID-19 public health and economic crisis.

To date, about $291 billion, or 71 percent of financial support earmarked for the health industry, has been disbursed or committed. 

Here's where some of the money has gone: 

Grants to health providers: $117 billion
Accelerated and advance Medicare payments to hospitals: $92 billion
Accelerated and advance Medicare payments to physicians: $8 billion
Moderna vaccine funding: $2 billion
GlaxoSmithKline vaccine funding: $2 billion
Pfizer vaccine funding: $2 billion
Novavax vaccine funding: $2 billion
Johnson & Johnson vaccine funding: $2 billion
AstraZeneca vaccine funding: $1 billion
Regeneron Therapeutic funding: $450 million

To view the full report, click here


Copyright © 2024 Becker's Healthcare. All Rights Reserved. Privacy Policy. Cookie Policy. Linking and Reprinting Policy.


Featured Whitepapers

Featured Webinars